go back

G(M2)-GANGLIOSIDOSIS: GM2 ACTIVATOR DEFICIENCY

G(M2)-GANGLIOSIDOSIS: GM2 ACTIVATOR DEFICIENCY
TAY-SACHS DISEASE, AB VARIANT; G(M2)-GANGLIOSIDOSIS WITH HEXOAMINIDASE A DEFICIENCY
272750
OMIM = Online Mendelian Inheritance of Men
309246
Ganglioside GM2 activator
5q33.1

Detail information to gene locus by the National Center for Biotechnology Information NCBI:
E75.0
very rare
autosomal recessive
mutation in the GM2A gene
infantile acute form, indistinguishable from infantile Tay-Sachs or Sandhoff disease
Laboratory findingsOligosaccharides inc (urine)
    GM2 activator protein dec (fibroblasts)
    L-Pyroglutamic acid (5-Oxoproline) inc (urine)
Symptomsblindness, visual loss, visual impairment
    cherry-red spot on retinal macula
    early death
    EEG abnormalities [-]
    hypertonia, spasticity
    hypotonia
    lethargy, drowsiness, apathy
    macrocephaly (large calvaria, >2 SD for age)
    mental retardation
    onset, infancy
    progressive neurologic defect
    seizures
    speech difficulties